While multiple studies describe FABP1 expression frequencies that are in the range of our findings in hepatocellular carcinomas [31–33], colorectal adenocarcinomas [16, 34], pancreatic adenocarcinomas [19], and gastric adenocarcinoma [17], we were unable to detect any FABP1-positive cases among 169 adenocarcinomas of the lung, 12 small cell carcinomas of the lung, and 157 chromophobe carcinomas of the kidney. Here, FABP1 is linked to colorectal adenocarcinoma.